Meds & supplements › Riluzole
Medicine · Benzothiazole
Riluzole
Riluzole tablets, USP are indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Drug facts
- Used for
- Riluzole tablets, USP are indicated for the treatment of amyotrophic lateral sclerosis (ALS).
- Do not take if
- TIGLUTIK is contraindicated in patients with a history of severe hypersensitivity reactions to riluzole or to any of its components (anaphylaxis has occurred).
What it is used for
TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Side effects, and when to stop
The following adverse reactions are described below and elsewhere in the labeling:
- Hepatic Injury
- Neutropenia
- Interstitial Lung Disease
- Pancreatitis
Who should not take it
TIGLUTIK is contraindicated in patients with a history of severe hypersensitivity reactions to riluzole or to any of its components (anaphylaxis has occurred).
Storing it
Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F), and protect from bright light. Do not freeze. Store upright.
Use within 15 days after initially opening of each bottle. Discard any unused TIGLUTIK remaining after 15 days of first opening of the bottle.
Cite this page
- NLM
sofidex [Internet]. Daloreum; c2026. Riluzole; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/riluzole
- APA 7th
sofidex. (2026, August 3). Riluzole. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/riluzole
- AMA 11th
Riluzole. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/riluzole
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.